Sensus Healthcare, Inc. SRTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-06-03
Sensus Healthcare, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M |
| R&D expense | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M |
| SG&A expense | $7.9M | $7.1M | $5.2M | — | — |
| Operating income | -$10.3M | $8.1M | -$382,000 | $14.8M | $4.1M |
| Interest expense | — | -$932,000 | -$992,000 | -$380,000 | $2,000 |
| Income tax | -$1.9M | $2.4M | $167,000 | $3.7M | — |
| Net income | -$7.7M | $6.6M | $485,000 | $24.2M | $4.1M |
| EPS (diluted) | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 |
| Operating cash flow | $528,000 | -$831,000 | -$2.1M | -$1.4M | -$286,000 |
| Free cash flow | $332,000 | -$1.1M | -$2.4M | -$1.6M | -$414,000 |
| Cash & equivalents | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M |
| Inventory | $14.6M | $10.1M | $11.9M | $3.5M | $1.8M |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M |
| Shareholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M |
Source: SEC EDGAR filings · CIK 0001494891 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.